These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 6322367)
1. Naloxone blocks the effects of delta 9-tetrahydrocannabinol on serum luteinizing hormone and prolactin in rats. Kumar MS; Simpkins JW Subst Alcohol Actions Misuse; 1983; 4(5):347-53. PubMed ID: 6322367 [TBL] [Abstract][Full Text] [Related]
2. Effect of an acute dose of delta 9-THC on hypothalamic luteinizing hormone releasing hormone and met-enkephalin content and serum levels of testosterone and corticosterone in rats. Kumar MS; Chen CL Subst Alcohol Actions Misuse; 1983; 4(1):37-43. PubMed ID: 6312620 [TBL] [Abstract][Full Text] [Related]
3. Tolerance to the luteinizing hormone and prolactin suppressive effects of delta-9-tetrahydrocannabinol develops during chronic prepubertal treatment of female rats. Field E; Tyrey L J Pharmacol Exp Ther; 1986 Sep; 238(3):1034-8. PubMed ID: 3018216 [TBL] [Abstract][Full Text] [Related]
4. Modulation of endogenous opioid influence on luteinizing hormone secretion by progesterone and estrogen. Gabriel SM; Simpkins JW; Kalra SP Endocrinology; 1983 Nov; 113(5):1806-11. PubMed ID: 6313330 [TBL] [Abstract][Full Text] [Related]
5. The effect of hyperprolactinemia produced by transplantable pituitary MtTW15 tumor cells in male rats on hypothalamic luteinizing hormone-releasing hormone release in vitro: effects of naloxone and K+. Kalra PS; Kalra SP Endocrinology; 1987 Jul; 121(1):310-5. PubMed ID: 3297642 [TBL] [Abstract][Full Text] [Related]
6. Effect of chronic administration of delta 9-tetrahydrocannabinol on the endogenous opioid peptide and catecholamine levels in the diencephalon and plasma of the rat. Kumar MS; Patel V; Millard WJ Subst Alcohol Actions Misuse; 1984; 5(4):201-10. PubMed ID: 6098037 [TBL] [Abstract][Full Text] [Related]
7. An opioid-neuropeptide-Y transmission line to luteinizing hormone (LH)-releasing hormone neurons: a role in the induction of LH surge. Sahu A; Crowley WR; Kalra SP Endocrinology; 1990 Feb; 126(2):876-83. PubMed ID: 2404749 [TBL] [Abstract][Full Text] [Related]
8. Central nervous system peptide and amino acid modulation of luteinizing hormone and prolactin secretion in the pig. Kraeling RR; Barb CR; Leshin LS; Rampacek GB J Physiol Pharmacol; 1992 Dec; 43(4 Suppl 1):79-103. PubMed ID: 1343978 [TBL] [Abstract][Full Text] [Related]
9. Naloxone does not reverse the inhibitory effect of morphine on luteinizing hormone secretion in prepubescent male rats. Cicero TJ; Nock B; O'Connor L J Pharmacol Exp Ther; 1993 Jan; 264(1):47-53. PubMed ID: 8380870 [TBL] [Abstract][Full Text] [Related]
10. Endogenous opioid peptides mediate the interleukin-1-induced inhibition of the release of luteinizing hormone (LH)-releasing hormone and LH. Kalra PS; Fuentes M; Sahu A; Kalra SP Endocrinology; 1990 Nov; 127(5):2381-6. PubMed ID: 2226323 [TBL] [Abstract][Full Text] [Related]
11. Decreases in mediobasal hypothalamic and preoptic area opioid ([3H]naloxone) binding are associated with the progesterone-induced luteinizing hormone surge. Jacobson W; Kalra SP Endocrinology; 1989 Jan; 124(1):199-206. PubMed ID: 2535804 [TBL] [Abstract][Full Text] [Related]
12. A decrease in opioid tone amplifies the luteinizing hormone surge in estrogen-treated ovariectomized rats: comparisons with progesterone effects. Masotto C; Sahu A; Dube MG; Kalra SP Endocrinology; 1990 Jan; 126(1):18-25. PubMed ID: 2293982 [TBL] [Abstract][Full Text] [Related]
14. Estrogen modulates the action of nitric oxide in the medial preoptic area on luteinizing hormone and prolactin secretion. Moreno AS; Franci CR Life Sci; 2004 Mar; 74(16):2049-59. PubMed ID: 14967199 [TBL] [Abstract][Full Text] [Related]
15. Effects of delta-9-tetrahydrocannabinol on reproductive neuroendocrine function in the female: animal studies. Tyrey L; Murphy LL NIDA Res Monogr; 1984; 55():42-51. PubMed ID: 6100504 [TBL] [Abstract][Full Text] [Related]
16. A decline in endogenous opioid influence during the steroid-induced hypersecretion of luteinizing hormone in the rat. Gabriel SM; Berglund LA; Simpkins JW Endocrinology; 1986 Feb; 118(2):558-61. PubMed ID: 3510853 [TBL] [Abstract][Full Text] [Related]
17. [Possible mechanisms of the interaction between gonadotropins and prolactin in an experimental hyperprolactinemia model]. Tresguerres JA; Esquifino AI Acta Physiol Lat Am; 1983; 33(3):257-74. PubMed ID: 6424409 [TBL] [Abstract][Full Text] [Related]
18. Age-related differences in the sensitivity of serum luteinizing hormone to prototypic mu, kappa and delta opiate agonists and antagonists. Cicero TJ; Meyer ER; Miller BT; Bell RD J Pharmacol Exp Ther; 1988 Jul; 246(1):14-20. PubMed ID: 2839658 [TBL] [Abstract][Full Text] [Related]
19. Bicuculline infusions advance the timing of luteinizing hormone surge in proestrous rats: comparisons with naloxone effects. Kimura F; Jinnai K Horm Behav; 1994 Dec; 28(4):424-30. PubMed ID: 7729810 [TBL] [Abstract][Full Text] [Related]
20. Endocrine aspects of cannabinoid action in female subprimates: search for sites of action. Tyrey L NIDA Res Monogr; 1984; 44():65-81. PubMed ID: 6090910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]